Back to results
US 2021/0253513 A1Published application
A novel process for the preparation of tapentadol
AssigneePharmathen S.A.
InventorsV. Theocharis KOFTIS, Efstratios NEOKOSMIDIS, Christos STATHAKIS, Petros GKIZIS, Theodoros PANAGIOTIDIS
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel process for the preparation of Tapentadol and intermediate compound 2R,3R)-3-(-methoxyphenyl)-N,N,2-trimethylpentanamine (compound of formula IIa).
Claims12
A process for the preparation of a compound of formula IIa or salt thereof from compound of formula IIIa or a salt thereof, comprising:
- a) performing deoxygenation of the compound of formula IIIa or a salt thereof in the presence of at least one hydrosilane reagent and at least one first acid selected from the group consisting of Lewis acids and protic acids, to provide the compound of formula IIa, optionally in the form of a diastereomeric mixture
(canceled)
(canceled)
Dependencies are inferred from the claim text.